Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK139 in Prurigo Nodularis
NCT07883213Phase 2Not yet recruiting
- Sponsor
- Akeso, Inc.
- Start
- Oct 2026
- Primary completion
- Aug 2027
01
Overview
A Phase 2 trial of AK139 in prurigo nodularis (PN), sponsored by Akeso, Inc.. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
AK139
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on NCT07883213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07883213.